Bio-Techne
Bio-Techne returns on capital
Annual and trailing 12-month returns on invested capital, equity and assets.
ROIC
% · Annual / TTM
ROCE
% · Annual / TTM
ROIIC
% · Annual / TTM
ROE
% · Annual / TTM
ROA
% · Annual / TTM
ROIC − WACC
Percentage points · Scenario
Quarterly data
| Fiscal period | Ended | ROIC% | ROCE% | ROIIC% | ROE% | ROA% | ROIC − WACCPercentage points |
|---|---|---|---|---|---|---|---|
| FY 2026 Q4 | Jun 30, 2026 | — | 10.48% | — | 9.03% | 7.07% | — |
| FY 2026 Q3 | Mar 31, 2026 | — | 6.31% | — | 5.34% | 4.22% | — |
| FY 2026 Q2 | Dec 31, 2025 | — | 4.78% | — | 3.96% | 3.12% | — |
| FY 2026 Q1 | Sep 30, 2025 | — | 4.42% | — | — | 2.96% | — |
| FY 2025 Q4 | Jun 30, 2025 | — | 4.15% | — | 3.68% | 2.79% | — |
| FY 2025 Q3 | Mar 31, 2025 | — | 6.81% | — | 6.53% | 4.91% | — |
| FY 2025 Q2 | Dec 31, 2024 | — | 7.84% | — | 7.82% | 5.86% | — |
| FY 2025 Q1 | Sep 30, 2024 | — | 7.31% | — | 7.29% | 5.49% | — |
| FY 2024 Q4 | Jun 30, 2024 | — | 8.18% | — | 8.33% | 6.29% | — |
| FY 2024 Q3 | Mar 31, 2024 | — | 10.15% | — | 10.4% | 7.63% | — |
| FY 2024 Q2 | Dec 31, 2023 | — | 11.12% | — | 11.82% | 8.8% | — |
| FY 2024 Q1 | Sep 30, 2023 | — | 12.33% | — | 13.16% | 9.66% | — |
| FY 2023 Q4 | Jun 30, 2023 | — | 12.92% | — | 15.55% | 11.56% | — |
| FY 2023 Q3 | Mar 31, 2023 | — | 12.41% | — | 15.05% | 11.07% | — |
| FY 2023 Q2 | Dec 31, 2022 | — | 13.47% | — | 14.83% | 11.22% | — |
| FY 2023 Q1 | Sep 30, 2022 | — | 13.32% | — | 17.22% | 12.64% | — |
| FY 2022 Q4 | Jun 30, 2022 | 14.8% | 14.02% | 49.9% | 16.66% | 11.94% | 6.9 pp |
| FY 2022 Q3 | Mar 31, 2022 | 15.8% | 13.95% | 33.72% | 13.85% | 10.29% | 7.9 pp |
| FY 2022 Q2 | Dec 31, 2021 | 15.22% | 12.82% | 54.62% | 13.05% | 9.63% | 7.3 pp |
| FY 2022 Q1 | Sep 30, 2021 | 14.95% | 12.31% | 67.14% | 11.47% | 8.17% | 7 pp |
| FY 2021 Q4 | Jun 30, 2021 | 13.53% | 11.77% | 76.12% | 9.53% | 6.55% | 5.6 pp |
| FY 2021 Q3 | Mar 31, 2021 | 12.05% | 10.83% | 276.87% | 13.02% | 9.03% | 4.2 pp |
| FY 2021 Q2 | Dec 31, 2020 | 10.05% | 9.74% | 3,807.56% | 12.29% | 8.6% | 2.1 pp |
| FY 2021 Q1 | Sep 30, 2020 | 9.15% | 9.15% | 49.37% | 18.98% | 12.48% | 1.3 pp |
| FY 2020 Q4 | Jun 30, 2020 | 8.26% | 8.5% | 22% | 17.99% | 11.72% | 0.4 pp |
| FY 2020 Q3 | Mar 31, 2020 | 8.11% | 8.8% | — | 15.32% | 9.66% | 0.2 pp |
| FY 2020 Q2 | Dec 31, 2019 | — | 8.64% | — | 16.11% | 10.15% | — |
| FY 2020 Q1 | Sep 30, 2019 | 8.16% | 8.51% | — | 8.14% | 4.9% | 0.3 pp |
| FY 2019 Q4 | Jun 30, 2019 | — | 8.9% | — | 8.55% | 5.53% | — |
| FY 2019 Q3 | Mar 31, 2019 | — | 8.81% | — | 11% | 6.95% | — |
| FY 2019 Q2 | Dec 31, 2018 | — | 9.08% | — | 9.2% | 5.67% | — |
| FY 2019 Q1 | Sep 30, 2018 | — | 8.47% | — | 12.33% | 7.51% | — |
| FY 2018 Q4 | Jun 30, 2018 | — | 9.28% | — | 12.43% | 8.01% | — |
| FY 2018 Q3 | Mar 31, 2018 | — | 9.53% | — | 11.39% | 7.11% | — |
| FY 2018 Q2 | Dec 31, 2017 | — | 9.09% | — | 12.04% | 7.39% | — |
| FY 2018 Q1 | Sep 30, 2017 | — | 8.56% | — | 7.67% | 4.68% | — |
| FY 2017 Q4 | Jun 30, 2017 | — | 9.65% | — | 8.32% | 5.66% | — |
| FY 2017 Q3 | Mar 31, 2017 | — | 9.24% | — | 7.91% | 5.24% | — |
| FY 2017 Q2 | Dec 31, 2016 | — | 10.02% | — | 8.99% | 5.92% | — |
| FY 2017 Q1 | Sep 30, 2016 | — | 11.63% | — | 11.31% | 7.41% | — |
| FY 2016 Q4 | Jun 30, 2016 | — | 14.35% | — | 12.1% | 9.53% | — |
| FY 2016 Q3 | Mar 31, 2016 | — | 0.14% | — | 12.57% | 9.45% | — |
| FY 2016 Q2 | Dec 31, 2015 | — | -0.24% | — | 11.83% | 8.81% | — |
| FY 2016 Q1 | Sep 30, 2015 | — | -0.39% | — | 13.06% | 9.93% | — |
| FY 2015 Q4 | Jun 30, 2015 | — | 0.02% | — | 13.12% | 11.19% | — |
| FY 2015 Q3 | Mar 31, 2015 | — | 15.82% | — | 13.55% | 11.19% | — |
| FY 2015 Q2 | Dec 31, 2014 | — | 16.65% | — | 14.73% | 12.03% | — |
| FY 2015 Q1 | Sep 30, 2014 | — | 17.92% | — | 14.13% | 11.95% | — |
| FY 2014 Q4 | Jun 30, 2014 | — | 20.19% | — | 14.48% | 13.53% | — |
| FY 2014 Q3 | Mar 31, 2014 | — | 20.95% | — | 15.04% | 14.15% | — |
| FY 2014 Q2 | Dec 31, 2013 | — | 21.42% | — | 15.8% | 14.94% | — |
| FY 2014 Q1 | Sep 30, 2013 | — | 22.1% | — | 16.25% | 15.33% | — |
| FY 2013 Q4 | Jun 30, 2013 | — | 22.17% | — | 15.94% | 15.03% | — |
| FY 2013 Q3 | Mar 31, 2013 | — | 23.15% | — | 16.33% | 15.42% | — |
| FY 2013 Q2 | Dec 31, 2012 | — | 24.71% | — | 17.03% | 16.31% | — |
| FY 2013 Q1 | Sep 30, 2012 | — | 25.24% | — | 17.4% | 16.48% | — |
| FY 2012 Q4 | Jun 30, 2012 | — | 25.91% | — | 17.82% | 16.8% | — |
| FY 2012 Q3 | Mar 31, 2012 | — | 27.48% | — | 18.74% | 17.91% | — |
| FY 2012 Q2 | Dec 31, 2011 | — | 28.81% | — | 19.79% | 19.11% | — |
| FY 2012 Q1 | Sep 30, 2011 | — | 29.43% | — | 20.39% | 19.43% | — |
| FY 2011 Q4 | Jun 30, 2011 | — | — | — | — | — | — |
| FY 2011 Q3 | Mar 31, 2011 | — | — | — | — | — | — |
| FY 2011 Q2 | Dec 31, 2010 | — | — | — | — | — | — |
| FY 2011 Q1 | Sep 30, 2010 | — | — | — | — | — | — |
Sources and calculations
Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.
Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.
Quarterly returns use trailing 12-month earnings and period-end balances averaged with the same fiscal quarter one year earlier. NOPAT uses the reported effective tax rate only when pretax profit is positive and the rate is between 0 and 100%. WACC starts at 7.9%, rounded from the Pharmaceuticals benchmark in NYU Stern · January 2026. It is an editable US sector proxy applied across history, not a company estimate; foreign reporting currencies also need a currency-specific assessment.
Market prices: Yahoo Finance · TECH, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.
- ROIC
- NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
- ROCE
- Operating income / average (assets − current liabilities) × 100, using period end and one year earlier.
- ROIIC
- Year-over-year change in annual/TTM NOPAT / positive year-over-year change in invested capital × 100. Capital reductions and missing inputs yield unavailable values.
- ROE
- Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
- ROA
- Net income / average total assets × 100, using period end and one year earlier.
- ROIC − WACC
- ROIC less your WACC assumption, in percentage points. The same scenario rate is applied across history; it is not a reported or historical company WACC.